Rare Disease Genetic Testing: Illuminating the Path to Precise Diagnoses"

According to BIS Research, The global Rare Disease Genetic Testing Market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.

Explore detailed insights at: https://bisresearch.com/indust....ry-report/rare-disea